DUBLIN, Oct. 2, 2013 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced the appointment of its Board of Directors, effective until the next annual meeting of shareholders in May 2014. The appointment of the Actavis plc Board follows the completion of Actavis, Inc.'s acquisition of Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion. The combination creates Actavis plc, a leading global specialty pharmaceutical company with approximately $11 billion in pro forma combined annual 2013 revenue, with approximately $3 billion in annual revenue focused on the core therapeutic categories of Women's Health, Urology, Gastroenterology and Dermatology. Actavis plc is headquartered in Dublin, Ireland.
Paul M. Bisaro, President and CEO of Actavis plc, has been named Chairman of the Board. Andrew L. Turner, former Chairman of the Board of Actavis, Inc., has been named Lead Independent Director.
Mr. Bisaro will lead a 13-member Board comprised of seven former members of the Actavis, Inc., Board of Directors and one new member from Actavis management; four members of the former Warner Chilcott plc Board of Directors; and one new independent director. The Board will have several standing committees, including an Audit Committee, Compensation Committee, Corporate Governance Committee and Quality and Operations Committee.Actavis plc Board of Directors
Paul M. Bisaro Paul M. Bisaro has served as Actavis, Inc.'s President and Chief Executive Officer and a member of the Company's Board of Directors since 2007. Prior to joining Actavis, Inc., Mr. Bisaro was President, Chief Operating Officer and a member of the Board of Directors of Barr Pharmaceuticals, Inc., a global specialty pharmaceutical company ("Barr"), from 1999 to 2007. Between 1992 and 1999, Mr. Bisaro served as General Counsel of Barr, and from 1997 to 1999 served in various additional capacities including Senior Vice President — Strategic Business Development. Prior to joining Barr, he was associated with the law firm Winston & Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds from 1989 to 1992. Mr. Bisaro holds an undergraduate degree in General Studies from the University of Michigan and a Juris Doctor from Catholic University of America in Washington, D.C. James H. Bloem James H. Bloem has been a member of the Warner Chilcott plc Board of Directors since 2006 and was a member of the Board of Directors of one of its predecessor companies from 1996 to 2000. Mr. Bloem is Senior Vice President, Chief Financial Officer and Treasurer of Humana Inc. ("Humana"), one of the nation's largest health benefit companies. He joined Humana in 2001 and has responsibility for all of the Company's accounting, actuarial, analytical, financial, tax, risk management, treasury and investor relations activities.